Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients With Severe Primary Mitral Regurgitation Eligible for High-risk Surgery

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 330 participants.

Also called NCT03271762

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 330 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03271762
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT03271762. Randomized; no masking; primary purpose treatment. Start 2018-03-02 (actual); primary completion 2026-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients With Severe Primary Mitral Regurgitation Eligible for High-risk Surgery
Acronym
MITRA-HR
Condition
Mitral Regurgitation
Intervention (Device)
percutaneous mitral valve repair with MITRACLIP NT, MITRACLIP NTR/XTR, MITRACLIP G4NT/XT, MITRACLIP G4NTW/XTW
Intervention (Procedure)
cardiac surgery
Lead sponsor
Nantes University Hospital (class: other)
Collaborator
Abbott (class: industry)
Collaborator
Ministry of Health, France (class: other government)

Record details

Record id
cardio:ct-nct03271762
Content hash
afadf391e57e796225d65682871a2bf7daa4032b49a8b1fbddb442303fe424ae